Changes

Line 33: Line 33:  
The Biotechnology Industry Organization filed a [[Community Objection|community objection]] against this application.<ref>[http://www.iccwbo.org/products-and-services/arbitration-and-adr/expertise/icann-new-gtld-dispute-resolution/pending-cases/ Pending Cases, ICC.ICANN.org]Retrieved 15 May 2013</ref> This objection was later withdrawn by the objector.<ref>[http://newgtlds.icann.org/en/program-status/odr/determination Objection Determinations, ICANN.org] Retrieved 05 Nov 2013</ref>
 
The Biotechnology Industry Organization filed a [[Community Objection|community objection]] against this application.<ref>[http://www.iccwbo.org/products-and-services/arbitration-and-adr/expertise/icann-new-gtld-dispute-resolution/pending-cases/ Pending Cases, ICC.ICANN.org]Retrieved 15 May 2013</ref> This objection was later withdrawn by the objector.<ref>[http://newgtlds.icann.org/en/program-status/odr/determination Objection Determinations, ICANN.org] Retrieved 05 Nov 2013</ref>
   −
===Legal Rights Objection==
+
===Legal Rights Objection===
 
The Biotechnology Industry Organization also filed a [[Legal Rights Objection]] against this application. [[WIPO]] panelist Christopher J. Pibus determined that the applicant prevailed, and the objection was dismissed. The panelist decided that: "the Objector has failed to make out its case under the first criteria of Section 3.5.2  of the Guidebook. The evidence does not establish that the Respondent’s use of the <.bio> string will take unfair advantage of the distinctive character or reputation of the Objector’s BIO trade-marks."<ref>[http://newgtlds.icann.org/en/program-status/odr/determination Objections Determinations, ICANN.org] Retrieved 05 Nov 2013</ref>
 
The Biotechnology Industry Organization also filed a [[Legal Rights Objection]] against this application. [[WIPO]] panelist Christopher J. Pibus determined that the applicant prevailed, and the objection was dismissed. The panelist decided that: "the Objector has failed to make out its case under the first criteria of Section 3.5.2  of the Guidebook. The evidence does not establish that the Respondent’s use of the <.bio> string will take unfair advantage of the distinctive character or reputation of the Objector’s BIO trade-marks."<ref>[http://newgtlds.icann.org/en/program-status/odr/determination Objections Determinations, ICANN.org] Retrieved 05 Nov 2013</ref>